Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Voss

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|March 24, 2012
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomesDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 20, 2012
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2012
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
JAMA Internal Medicine|January 6, 2017
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical TrialAshley B Irish, Andrea K Viecelli, Carmel M Hawley, et al.
Nephrology (Carlton, Vic.)|May 26, 2018
Identifying and integrating patient and caregiver perspectives in clinical practice guidelines for percutaneous renal biopsyTalia Gutman, Pamela Lopez-Vargas, Karine E Manera, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 18, 2021
Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre-specified cross-sectional study of the FAVOURED trial participantsMarguerite Conley, Anne Barden, Andrea K Viecelli, et al.
Nephrology (Carlton, Vic.)|January 3, 2017
Teaching peritoneal dialysis in Australia: An opportunity for improvementNeil Boudville, Yeoungjee Cho, Keri-Lu Equinox, et al.
Kidney360|April 4, 2022
Predictors of Arteriovenous Fistula Failure: A <i>Post Hoc</i> Analysis of the FAVOURED StudyYong Pey See, Yeoungjee Cho, Elaine M Pascoe, et al.
The Clinical Biochemist. Reviews|February 2, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statementNagesh Anavekar, Renze Bais, Shane Carney, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|March 24, 2012
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomesDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 20, 2012
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2012
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
JAMA Internal Medicine|January 6, 2017
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical TrialAshley B Irish, Andrea K Viecelli, Carmel M Hawley, et al.
Nephrology (Carlton, Vic.)|May 26, 2018
Identifying and integrating patient and caregiver perspectives in clinical practice guidelines for percutaneous renal biopsyTalia Gutman, Pamela Lopez-Vargas, Karine E Manera, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 18, 2021
Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre-specified cross-sectional study of the FAVOURED trial participantsMarguerite Conley, Anne Barden, Andrea K Viecelli, et al.
Nephrology (Carlton, Vic.)|January 3, 2017
Teaching peritoneal dialysis in Australia: An opportunity for improvementNeil Boudville, Yeoungjee Cho, Keri-Lu Equinox, et al.
Kidney360|April 4, 2022
Predictors of Arteriovenous Fistula Failure: A <i>Post Hoc</i> Analysis of the FAVOURED StudyYong Pey See, Yeoungjee Cho, Elaine M Pascoe, et al.
The Clinical Biochemist. Reviews|February 2, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statementNagesh Anavekar, Renze Bais, Shane Carney, et al.
Pageof 4